Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Lisa Battista

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Stem Cell Research & Therapy|May 16, 2009
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complications after allogeneic stem cell transplantationFrancesca Patriarca, Venerino Poletti, Ulrich Costabel, et al.
Transplantation Direct|January 23, 2026
Intensification of Treosulfan-Fludarabine Conditioning With Thiotepa Exhibited Effectiveness and Tolerability in Older or Comorbid Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant With Active Myeloid Neoplasm: A Real-world StudyLuca Tosoni, Gabriele Facchin, Rosa Plos, et al.
Frontiers in Immunology|September 2, 2025
Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensityUmberto Pizzano, Simona Piemontese, Gabriele Facchin, et al.
Blood|January 24, 2012
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2025
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case ReportAnna Favero, Sara Mohamed, Marta Lisa Battista, et al.
European Journal of Haematology|June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopeniaFrancesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Journal of Clinical Medicine|July 27, 2022
Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD)Gabriele Facchin, Chiara Savignano, Marta Lisa Battista, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2016
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell TransplantationFrancesca Patriarca, Chiara Cigana, Dozzo Massimo, et al.
Bone Marrow Transplantation|June 1, 2021
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT studyMohamad Mohty, Marta Lisa Battista, Didier Blaise, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 7, 2023
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccinationUmberto Pizzano, Gabriele Facchin, Chiara Marcon, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Stem Cell Research & Therapy|May 16, 2009
Clinical presentation, outcome and risk factors of late-onset non-infectious pulmonary complications after allogeneic stem cell transplantationFrancesca Patriarca, Venerino Poletti, Ulrich Costabel, et al.
Transplantation Direct|January 23, 2026
Intensification of Treosulfan-Fludarabine Conditioning With Thiotepa Exhibited Effectiveness and Tolerability in Older or Comorbid Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant With Active Myeloid Neoplasm: A Real-world StudyLuca Tosoni, Gabriele Facchin, Rosa Plos, et al.
Frontiers in Immunology|September 2, 2025
Post-transplant cyclophosphamide in haploidentical stem cell transplantation: evaluating the impact of transplant conditioning intensityUmberto Pizzano, Simona Piemontese, Gabriele Facchin, et al.
Blood|January 24, 2012
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Francesco Zaja, Anna Zaninoni, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 17, 2025
Immune Effector Cell-Associated Neurotoxicity Delayed Relapse After Chimeric Antigen Receptor T-Cell Therapy: A Case ReportAnna Favero, Sara Mohamed, Marta Lisa Battista, et al.
European Journal of Haematology|June 16, 2010
Low-dose rituximab in adult patients with primary immune thrombocytopeniaFrancesco Zaja, Nicola Vianelli, Stefano Volpetti, et al.
Journal of Clinical Medicine|July 27, 2022
Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD)Gabriele Facchin, Chiara Savignano, Marta Lisa Battista, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2016
Risk Factors and Outcomes of Infections by Multidrug-Resistant Gram-Negative Bacteria in Patients Undergoing Hematopoietic Stem Cell TransplantationFrancesca Patriarca, Chiara Cigana, Dozzo Massimo, et al.
Bone Marrow Transplantation|June 1, 2021
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT studyMohamad Mohty, Marta Lisa Battista, Didier Blaise, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 7, 2023
Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccinationUmberto Pizzano, Gabriele Facchin, Chiara Marcon, et al.
Pageof 2